Dyne Therapeutics Inc. (DYN) – New Coverage
-
H.C. Wainwright Starts Dyne Therapeutics (DYN) at Buy
-
Oppenheimer Starts Dyne Therapeutics (DYN) at Outperform, 'A FORCEful Approach, Overcoming Oligonucleotide Delivery Limitations in Muscle'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DYN Stock Lookup